Connect with us

INDUSTRIAL HEMP

Axim Biotechnologies Inc (OTCMKTS:AXIM) Makes A Strong Move Towards North

Published

on

Axim Biotechnologies Inc

As per a report issued by New Frontier Data, permitted cannabis sales in California are estimated to reach $2.8 billion in 2017, with a compound yearly growth rate of 12% during the forecast year, and the companies in focus are Axim Biotechnologies Inc (OTCMKTS:AXIM), CANNABIS WHEATON I (OTCMKTS:CBWTF), Vitality Biopharma Inc (OTCMKTS:VBIO), Kush Bottles Inc (OTCMKTS:KSHB) and GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).

The details

The report also suggested that young people between the ages of 18 and 34-year account for 80% of cannabis e-commerce and delivery purchases in the state of California. Giadha Aguirre de Carcer, the CEO of New Frontier Data, expressed that considerable changes are already ongoing in California for adult use and medical cannabis laws, which they witness will have key implications for the cannabis market, including ecommerce and supply services in the state. As the largest prospective market for cannabis offerings and the largest state in the nation, the implications for the growth of the market because of California’s adult use segment cannot be overstated.

According to a report issued by New Frontier Data, the legal cannabis industry was valued at $6.6 billion in 2016 and is projected to rise to $24.1 billion by 2025 and at a compound yearly growth rate of 16%. The market is growing fast due to growing pace of legalization for both recreational as well as medical cannabis in the U.S. Last November, California has approved California Proposition 64 by a vote of 42.87% against and 57.13% for, enabling individuals in California to grow and use cannabis for personal use.

Axim Biotechnologies reported recently that the USPTO has issued a Notice of Allowance for a patent that claims the application of an ophthalmic solution containing cannabinoids for the cure of glaucoma and symptomatic respite of conjunctival inflammation.

In the last trading session, the stock price of Axim jumped more than 7% to close the day at $6.49.


 

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement